Three years after discussing how to reuse an old scientific measuring device, Novartis scientists are now testing this idea as part of an innovative research project.

Compounds that block the production of damaging molecules might shed light on their role in disease—and lead to new therapies.

The cause of a rare, inherited, often fatal kidney disease in many patients remained elusive for years, despite multiple attempts to solve the mystery. Then in 2012, a team of researchers cracked some of the unsolved cases in just six weeks.

Making clinical tools from basic research knowledge is a practice Novartis and FMI researchers pursue. Read how they want to help retinitis pigmentosa patients to see the light.

Lisa, a patient living with CML, shares her experience and discusses the importance of speaking up about unmet needs in your disease.

Melanoma survivor T.J. Sharpe discusses the importance of clinical trials to help raise awareness among the community.

Global Oncology Patient Insights Panels (GOPIPs) are giving patients and advocates a critical voice in advancing lung cancer trials.

Graf explains how flexible working has contributed to her success.

Sturchler and Wrynn explain why their job-sharing experience was one of the most successful and energizing periods of their careers.